Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses

► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. ► After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. ► Co-infections together with influenza vi...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 30; no. 3; pp. 517 - 522
Main Authors Roth, Bernhard, Mohr, Hannah, Enders, Martin, Garten, Wolfgang, Gregersen, Jens-Peter
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 11.01.2012
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. ► After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. ► Co-infections together with influenza virus were lost within 2–3 MDCK passages. ► MDCK cells represent a barrier for co-infecting viruses in influenza vaccine strains. This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼104), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses.
AbstractList ► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. ► After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. ► Co-infections together with influenza virus were lost within 2–3 MDCK passages. ► MDCK cells represent a barrier for co-infecting viruses in influenza vaccine strains. This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼10 4 ), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses.
This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼10(4)), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses.This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼10(4)), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses.
Highlights► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. ► After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. ► Co-infections together with influenza virus were lost within 2–3 MDCK passages. ► MDCK cells represent a barrier for co-infecting viruses in influenza vaccine strains.
► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. ► After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. ► Co-infections together with influenza virus were lost within 2–3 MDCK passages. ► MDCK cells represent a barrier for co-infecting viruses in influenza vaccine strains. This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼104), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses.
This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼10(4)), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses.
Highlights * Multiplex PCR screening of clinical specimens from acute respiratory tract infections. * Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. * After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. * Co-infections together with influenza virus were lost within 2-3 MDCK passages. * MDCK cells represent a barrier for co-infecting viruses in influenza vaccine strains.
This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼10⁴), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses.
This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ~104), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses.
Author Enders, Martin
Gregersen, Jens-Peter
Mohr, Hannah
Garten, Wolfgang
Roth, Bernhard
AuthorAffiliation a Novartis Vaccines and Diagnostics GmbH, Emil von Behring Str. 76, 35041 Marburg, Germany
b Phillips University Marburg, Institute for Virology, Hans-Meerwein-Straße 2, 35043 Marburg, Germany
c Laboratory Prof. G. Enders & Partners, Rosenbergstraße 85, 70193 Stuttgart, Germany
AuthorAffiliation_xml – name: b Phillips University Marburg, Institute for Virology, Hans-Meerwein-Straße 2, 35043 Marburg, Germany
– name: c Laboratory Prof. G. Enders & Partners, Rosenbergstraße 85, 70193 Stuttgart, Germany
– name: a Novartis Vaccines and Diagnostics GmbH, Emil von Behring Str. 76, 35041 Marburg, Germany
Author_xml – sequence: 1
  givenname: Bernhard
  surname: Roth
  fullname: Roth, Bernhard
  email: bernhard.roth@novartis.com
  organization: Novartis Vaccines and Diagnostics GmbH, Emil von Behring Str. 76, 35041 Marburg, Germany
– sequence: 2
  givenname: Hannah
  surname: Mohr
  fullname: Mohr, Hannah
  organization: Novartis Vaccines and Diagnostics GmbH, Emil von Behring Str. 76, 35041 Marburg, Germany
– sequence: 3
  givenname: Martin
  surname: Enders
  fullname: Enders, Martin
  organization: Laboratory Prof. G. Enders & Partners, Rosenbergstraße 85, 70193 Stuttgart, Germany
– sequence: 4
  givenname: Wolfgang
  surname: Garten
  fullname: Garten, Wolfgang
  organization: Phillips University Marburg, Institute for Virology, Hans-Meerwein-Straße 2, 35043 Marburg, Germany
– sequence: 5
  givenname: Jens-Peter
  surname: Gregersen
  fullname: Gregersen, Jens-Peter
  organization: Novartis Vaccines and Diagnostics GmbH, Emil von Behring Str. 76, 35041 Marburg, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22119922$$D View this record in MEDLINE/PubMed
BookMark eNqNk11v0zAYhS00xLrCTwAicQE3Lf5IYluIIVQYTAyBNCZxZznOm-IutYudVCq_Hod2AyrBJlmKlDzn2O_J8RE6cN4BQg8JnhJMyueL6VobYx1MKSZkmhYu2R00IoKzCS2IOEAjTMt8khP89RAdxbjAGBeMyHvokFJCpKR0hOan0be6s95lvsmsa9oe3A-drW3oI8T0Jvv4ZvYhYyxt-vkkM9C2MdOuzkwLOmhnYBAa7zq9tC45uXkWIK5s0J0Pmyuj--huo9sID3bPMbo4eftl9n5y9und6ez12cTwQnQTKKXgHCRwrVllKOQci4JQzkDTvDGigKJqoDSMVlSYvG5YVbGEiVrLugA2Rsdb31VfLaE24LqgW7UKdqnDRnlt1d9fnP2m5n6tOGFYEJYMnu4Mgv_eQ-zU0sZhau3A91FJIlKKnJFbkJRLLkSZyGf_JUnJRUGlzGlCn-yhC98HlyJTJJecSVoynKhHf055Pd7Vf01AsQVM8DEGaK4RgtXQH7VQu_6ooT8qrdSfpHuxpzO2-1WPFJZtb1Q_3qob7ZWeBxvVxXkCCoxJnro4nOvVloDUgbWFoKKxkEpU2wCmU7W3N-5xvOdgWuus0e0lbCD-TktFqrA6H-7AcAVI8hRFSnCMXv7b4BYH-AkuTxdN
CitedBy_id crossref_primary_10_1080_14760584_2019_1639503
crossref_primary_10_1080_21645515_2015_1016666
crossref_primary_10_1016_j_ajic_2020_05_026
crossref_primary_10_1016_j_vaccine_2014_04_072
crossref_primary_10_1016_j_vaccine_2019_08_064
crossref_primary_10_1586_14760584_2015_1039520
crossref_primary_10_1016_j_vaccine_2016_05_031
crossref_primary_10_1038_s41541_018_0079_z
crossref_primary_10_1038_s41541_021_00415_3
crossref_primary_10_33321_cdi_2021_45_43
crossref_primary_10_1111_1348_0421_12985
crossref_primary_10_1111_irv_12694
crossref_primary_10_1099_vir_0_044388_0
crossref_primary_10_35772_ghm_2023_01070
Cites_doi 10.1128/JVI.64.4.1808-1811.1990
10.1016/j.vaccine.2009.02.064
10.1038/nbt1261
10.1007/s10096-009-0780-y
10.1016/j.vaccine.2008.03.076
10.1586/erv.09.128
10.1128/JCM.01621-06
10.1016/S0264-410X(03)00071-9
10.3201/eid1410.080545
10.1038/303706a0
10.1002/jmv.1890440403
10.1002/jmv.20243
10.1086/508219
10.1128/JCM.38.3.1170-1174.2000
10.1111/j.1651-2227.2008.01023.x
10.1002/rmv.1980030206
10.1093/infdis/160.2.191
10.1128/JCM.41.1.149-154.2003
10.1016/S1386-6532(03)00122-7
10.1002/jmv.10225
10.1086/521308
10.1128/JCM.00027-07
10.1128/JCM.10.1.32-36.1979
10.1086/650171
10.1016/j.vaccine.2008.03.075
ContentType Journal Article
Copyright 2011 Elsevier Ltd
Elsevier Ltd
Copyright © 2011 Elsevier Ltd. All rights reserved.
Copyright Elsevier Limited Jan 11, 2012
Copyright © 2011 Elsevier Ltd. 2011 Elsevier Ltd
Copyright_xml – notice: 2011 Elsevier Ltd
– notice: Elsevier Ltd
– notice: Copyright © 2011 Elsevier Ltd. All rights reserved.
– notice: Copyright Elsevier Limited Jan 11, 2012
– notice: Copyright © 2011 Elsevier Ltd. 2011 Elsevier Ltd
DBID 6I.
AAFTH
FBQ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7S9
L.6
7X8
7ST
SOI
5PM
DOI 10.1016/j.vaccine.2011.11.063
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
AGRIS
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Consumer Health Database
Health & Medical Collection (Alumni)
Healthcare Administration Database
Medical Database
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
Environment Abstracts
Environment Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Public Health
ProQuest Central Basic
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
Environment Abstracts
DatabaseTitleList
MEDLINE - Academic


MEDLINE
Research Library Prep
AGRICOLA

AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
– sequence: 4
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2518
EndPage 522
ExternalDocumentID PMC7130813
3217319211
22119922
10_1016_j_vaccine_2011_11_063
US201500142642
S0264410X11018597
1_s2_0_S0264410X11018597
Genre Journal Article
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEUYN
AEVXI
AEXOQ
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGGSO
AGUBO
AGYEJ
AHMBA
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
AQUVI
AXJTR
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
FYUFA
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HMCUK
HZ~
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
Q38
ROL
RPZ
SAB
SCC
SDF
SDG
SDP
SES
SNL
SPCBC
SSH
SSI
SSZ
T5K
UKHRP
UV1
WH7
WOW
Z5R
~G-
.GJ
29Q
3V.
AACTN
AAQXK
ADVLN
AFCTW
AFJKZ
AFKWA
AGHFR
AHHHB
AJOXV
ALIPV
AMFUW
ASPBG
AVWKF
AZFZN
FEDTE
FGOYB
G-2
HEJ
HLV
HMG
HMK
HMO
HVGLF
HX~
R2-
RIG
SAE
SEW
SIN
SVS
WUQ
XPP
ZGI
ZXP
6I.
AAFTH
AAIAV
ABLVK
ABYKQ
AESVU
AJBFU
EFLBG
LCYCR
QYZTP
ABPIF
ABPTK
FBQ
AAYXX
ACMHX
ADSLC
AGQPQ
AGRNS
AGWPP
AIGII
APXCP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T5
7U9
7XB
8FK
C1K
H94
K9.
M7N
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7S9
L.6
7X8
7ST
SOI
5PM
ID FETCH-LOGICAL-c758t-e69877e9e7aa3bc2e470851273ea24fc85e5bfe6c32b28c4df3bb32e48da9d5e3
IEDL.DBID .~1
ISSN 0264-410X
1873-2518
IngestDate Thu Aug 21 18:14:29 EDT 2025
Tue Aug 05 10:12:09 EDT 2025
Thu Jul 10 23:30:50 EDT 2025
Mon Jul 21 10:15:15 EDT 2025
Wed Aug 13 11:32:37 EDT 2025
Thu Apr 03 07:07:06 EDT 2025
Thu Apr 24 23:09:14 EDT 2025
Tue Jul 01 03:37:56 EDT 2025
Wed Dec 27 19:21:10 EST 2023
Fri Feb 23 02:31:56 EST 2024
Sun Feb 23 10:19:15 EST 2025
Tue Aug 26 17:46:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords MDCK cells
Influenza vaccine
Virus isolation
Adventitious viruses
Language English
License http://creativecommons.org/licenses/by-nc-nd/3.0
https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2011 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c758t-e69877e9e7aa3bc2e470851273ea24fc85e5bfe6c32b28c4df3bb32e48da9d5e3
Notes http://dx.doi.org/10.1016/j.vaccine.2011.11.063
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0264410X11018597
PMID 22119922
PQID 1497392630
PQPubID 105530
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7130813
proquest_miscellaneous_918053731
proquest_miscellaneous_912797886
proquest_miscellaneous_1678529942
proquest_journals_1497392630
pubmed_primary_22119922
crossref_primary_10_1016_j_vaccine_2011_11_063
crossref_citationtrail_10_1016_j_vaccine_2011_11_063
fao_agris_US201500142642
elsevier_sciencedirect_doi_10_1016_j_vaccine_2011_11_063
elsevier_clinicalkeyesjournals_1_s2_0_S0264410X11018597
elsevier_clinicalkey_doi_10_1016_j_vaccine_2011_11_063
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-01-11
PublicationDateYYYYMMDD 2012-01-11
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-11
  day: 11
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: Kidlington
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2012
Publisher Elsevier Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
References Stempel, Martin, Kuypers, Englund, Zerr (bib0120) 2009; 98
Matthews (bib0100) 2006; 36
Katz, Webster (bib0020) 1989; 160
Dare, Sanghavi, Bullotta, Keightley, George, Wadowsky (bib0090) 2007; 45
Minor (bib0110) 2010; 50
Genzel, Reichl (bib0030) 2009; 8
Ulmer, Valley, Rappuoli (bib0105) 2006; 24
Manning, Russel, Eastick, Leadbetter, Hallam, Tempelton (bib0115) 2006; 194
Eggers, Roth, Schweiger, Schmid, Gregersen, Enders (bib0135) 2011
Gregersen (bib0040) 2008; 26
Mori, Clewley (bib0070) 1994; 44
Dare, Fry, Chittaganpitch, Sawanpanyalert, Olsen, Erdman (bib0080) 2007; 196
Oxford, Corcoran, Knott, Bates, Bartolomei, Major (bib0015) 1987; 65
Gerdil (bib0095) 2003; 21
Robertson (bib0010) 1993; 3
Ward, Dempsey, Ring, Kempson, Zhang, Gor (bib0050) 2004; 29
De Vos, Vankeerberghen, Vaeyens, Van Vaerenbergh, Boel, De Beenhouwer (bib0125) 2009; 28
Frank, Couch, Griffis, Baxter (bib0140) 1979; 10
Katz, Wang, Webster (bib0025) 1990; 64
Venter, Collinson, Schoub (bib0060) 2002; 68
Neske, Blessing, Tollmann, Schubert, Rethwilm, Kreth (bib0085) 2007; 45
Gregersen (bib0045) 2008; 26
Schild, Oxford, de Jong, Webster (bib0005) 1983; 303
Bosis, Esposito, Niesters, Crovari, Osterhaus, Principi (bib0130) 2005; 75
Minor, Engelhardt, Wood, Robertson, Trusheim, Blayer (bib0035) 2009; 27
Oberste, Maher, Flemister, Marchetti, Kilpatrick, Pallansch (bib0065) 2000; 38
Xiang, Gonzalez, Xie, Xiao, Chen, Li (bib0075) 2008; 14
Hu, Colella, Tam, Rappaport, Cheng (bib0055) 2003; 41
Katz (10.1016/j.vaccine.2011.11.063_bib0025) 1990; 64
Genzel (10.1016/j.vaccine.2011.11.063_bib0030) 2009; 8
Oberste (10.1016/j.vaccine.2011.11.063_bib0065) 2000; 38
Oxford (10.1016/j.vaccine.2011.11.063_bib0015) 1987; 65
Gregersen (10.1016/j.vaccine.2011.11.063_bib0040) 2008; 26
Matthews (10.1016/j.vaccine.2011.11.063_bib0100) 2006; 36
Robertson (10.1016/j.vaccine.2011.11.063_bib0010) 1993; 3
Manning (10.1016/j.vaccine.2011.11.063_bib0115) 2006; 194
Minor (10.1016/j.vaccine.2011.11.063_bib0110) 2010; 50
Gregersen (10.1016/j.vaccine.2011.11.063_bib0045) 2008; 26
De Vos (10.1016/j.vaccine.2011.11.063_bib0125) 2009; 28
Schild (10.1016/j.vaccine.2011.11.063_bib0005) 1983; 303
Dare (10.1016/j.vaccine.2011.11.063_bib0080) 2007; 196
Bosis (10.1016/j.vaccine.2011.11.063_bib0130) 2005; 75
Gerdil (10.1016/j.vaccine.2011.11.063_bib0095) 2003; 21
Xiang (10.1016/j.vaccine.2011.11.063_bib0075) 2008; 14
Stempel (10.1016/j.vaccine.2011.11.063_bib0120) 2009; 98
Katz (10.1016/j.vaccine.2011.11.063_bib0020) 1989; 160
Frank (10.1016/j.vaccine.2011.11.063_bib0140) 1979; 10
Ward (10.1016/j.vaccine.2011.11.063_bib0050) 2004; 29
Hu (10.1016/j.vaccine.2011.11.063_bib0055) 2003; 41
Eggers (10.1016/j.vaccine.2011.11.063_bib0135) 2011
Dare (10.1016/j.vaccine.2011.11.063_bib0090) 2007; 45
Neske (10.1016/j.vaccine.2011.11.063_bib0085) 2007; 45
Minor (10.1016/j.vaccine.2011.11.063_bib0035) 2009; 27
Venter (10.1016/j.vaccine.2011.11.063_bib0060) 2002; 68
Ulmer (10.1016/j.vaccine.2011.11.063_bib0105) 2006; 24
Mori (10.1016/j.vaccine.2011.11.063_bib0070) 1994; 44
References_xml – year: 2011
  ident: bib0135
  article-title: Comparison of the novel ResPlex III assay and existing techniques for the detection and subtyping of influenza virus during the influenza season 2006–2007
  publication-title: Eur J Microbiol Infect Dis
– volume: 27
  start-page: 2907
  year: 2009
  end-page: 2913
  ident: bib0035
  article-title: Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK
  publication-title: Vaccine
– volume: 26
  start-page: 3297
  year: 2008
  end-page: 3304
  ident: bib0040
  article-title: A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines
  publication-title: Vaccine
– volume: 29
  start-page: 179
  year: 2004
  end-page: 188
  ident: bib0050
  article-title: Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement
  publication-title: J Clin Virol
– volume: 64
  start-page: 1808
  year: 1990
  end-page: 1811
  ident: bib0025
  article-title: Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus
  publication-title: J Virol
– volume: 41
  start-page: 149
  year: 2003
  end-page: 154
  ident: bib0055
  article-title: Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR
  publication-title: J Clin Microbiol
– volume: 45
  start-page: 548
  year: 2007
  end-page: 552
  ident: bib0090
  article-title: Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis
  publication-title: J Clin Microbiol
– volume: 24
  start-page: 1377
  year: 2006
  end-page: 1383
  ident: bib0105
  article-title: Vaccine manufacturing: challenges and solutions
  publication-title: Nat Biotechnol
– volume: 98
  start-page: 123
  year: 2009
  end-page: 126
  ident: bib0120
  article-title: Multiple viral respiratory pathogens in children with bronchiolitis
  publication-title: Acta Paediatr
– volume: 28
  start-page: 1305
  year: 2009
  end-page: 1310
  ident: bib0125
  article-title: Simultaneous detection of human bocavirus and adenovirus by multiplex real-time PCR in a Belgian paediatric population
  publication-title: Eur J Clin Microbiol Infect Dis
– volume: 36
  start-page: 17
  year: 2006
  end-page: 24
  ident: bib0100
  article-title: Egg-based production of influenza vaccine: 30 years of commercial experience
  publication-title: The Bridge
– volume: 160
  start-page: 191
  year: 1989
  end-page: 198
  ident: bib0020
  article-title: Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs
  publication-title: J Infect Dis
– volume: 8
  start-page: 1681
  year: 2009
  end-page: 1692
  ident: bib0030
  article-title: Continuous cell lines as a production system for influenza vaccines
  publication-title: Expert Rev Vaccines
– volume: 50
  start-page: 560
  year: 2010
  end-page: 565
  ident: bib0110
  article-title: Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production
  publication-title: Clin Infect Dis
– volume: 14
  start-page: 1665
  year: 2008
  end-page: 1667
  ident: bib0075
  article-title: Human rhinovirus group C infection in children with lower respiratory tract infection
  publication-title: Emerg Infect Dis
– volume: 44
  start-page: 323
  year: 1994
  end-page: 329
  ident: bib0070
  article-title: Polymerase chain reaction and sequencing for typing rhinovirus RNA
  publication-title: J Med Virol
– volume: 26
  start-page: 3332
  year: 2008
  end-page: 3340
  ident: bib0045
  article-title: A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine
  publication-title: Vaccine
– volume: 10
  start-page: 32
  year: 1979
  end-page: 36
  ident: bib0140
  article-title: Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses
  publication-title: J Clin Microbiol
– volume: 303
  start-page: 706
  year: 1983
  end-page: 709
  ident: bib0005
  article-title: Evidence for host-cell selection of influenza virus antigenic variants
  publication-title: Nature
– volume: 68
  start-page: 452
  year: 2002
  end-page: 461
  ident: bib0060
  article-title: Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: comparison of viruses and genotypes responsible for different disease manifestations
  publication-title: J Med Virol
– volume: 194
  start-page: 1283
  year: 2006
  end-page: 1290
  ident: bib0115
  article-title: Epidemiological profile and clinical associations of human bocavirus and other human parvovirus
  publication-title: J Infect Dis
– volume: 75
  start-page: 101
  year: 2005
  end-page: 104
  ident: bib0130
  article-title: Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses
  publication-title: J Med Virol
– volume: 38
  start-page: 1170
  year: 2000
  end-page: 1174
  ident: bib0065
  article-title: Comparison of classic and molecular approaches for the identification of untypeable enteroviruses
  publication-title: J Clin Microbiol
– volume: 21
  start-page: 1776
  year: 2003
  end-page: 1779
  ident: bib0095
  article-title: The annual production cycle for influenza vaccine
  publication-title: Vaccine
– volume: 65
  start-page: 181
  year: 1987
  end-page: 187
  ident: bib0015
  article-title: Serological studies with influenza A (H1N1) viruses cultivated in eggs or in canine kidney cell line (MDCK)
  publication-title: Bull WHO
– volume: 45
  start-page: 2116
  year: 2007
  end-page: 2122
  ident: bib0085
  article-title: Real-time PCR for diagnosis of human bocavirus infections and phylogenetic analysis
  publication-title: J Clin Microbiol
– volume: 3
  start-page: 97
  year: 1993
  end-page: 106
  ident: bib0010
  article-title: Clinical influenza virus and the embryonated hen's egg
  publication-title: Med Virol
– volume: 196
  start-page: 1321
  year: 2007
  end-page: 1328
  ident: bib0080
  article-title: Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays
  publication-title: J Infect Dis
– volume: 65
  start-page: 181
  year: 1987
  ident: 10.1016/j.vaccine.2011.11.063_bib0015
  article-title: Serological studies with influenza A (H1N1) viruses cultivated in eggs or in canine kidney cell line (MDCK)
  publication-title: Bull WHO
– volume: 64
  start-page: 1808
  year: 1990
  ident: 10.1016/j.vaccine.2011.11.063_bib0025
  article-title: Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus
  publication-title: J Virol
  doi: 10.1128/JVI.64.4.1808-1811.1990
– volume: 27
  start-page: 2907
  year: 2009
  ident: 10.1016/j.vaccine.2011.11.063_bib0035
  article-title: Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.02.064
– volume: 36
  start-page: 17
  year: 2006
  ident: 10.1016/j.vaccine.2011.11.063_bib0100
  article-title: Egg-based production of influenza vaccine: 30 years of commercial experience
  publication-title: The Bridge
– volume: 24
  start-page: 1377
  year: 2006
  ident: 10.1016/j.vaccine.2011.11.063_bib0105
  article-title: Vaccine manufacturing: challenges and solutions
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt1261
– volume: 28
  start-page: 1305
  year: 2009
  ident: 10.1016/j.vaccine.2011.11.063_bib0125
  article-title: Simultaneous detection of human bocavirus and adenovirus by multiplex real-time PCR in a Belgian paediatric population
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-009-0780-y
– volume: 26
  start-page: 3297
  year: 2008
  ident: 10.1016/j.vaccine.2011.11.063_bib0040
  article-title: A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.03.076
– volume: 8
  start-page: 1681
  year: 2009
  ident: 10.1016/j.vaccine.2011.11.063_bib0030
  article-title: Continuous cell lines as a production system for influenza vaccines
  publication-title: Expert Rev Vaccines
  doi: 10.1586/erv.09.128
– volume: 45
  start-page: 548
  issue: February (2)
  year: 2007
  ident: 10.1016/j.vaccine.2011.11.063_bib0090
  article-title: Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01621-06
– volume: 21
  start-page: 1776
  year: 2003
  ident: 10.1016/j.vaccine.2011.11.063_bib0095
  article-title: The annual production cycle for influenza vaccine
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(03)00071-9
– volume: 14
  start-page: 1665
  year: 2008
  ident: 10.1016/j.vaccine.2011.11.063_bib0075
  article-title: Human rhinovirus group C infection in children with lower respiratory tract infection
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1410.080545
– volume: 303
  start-page: 706
  year: 1983
  ident: 10.1016/j.vaccine.2011.11.063_bib0005
  article-title: Evidence for host-cell selection of influenza virus antigenic variants
  publication-title: Nature
  doi: 10.1038/303706a0
– volume: 44
  start-page: 323
  year: 1994
  ident: 10.1016/j.vaccine.2011.11.063_bib0070
  article-title: Polymerase chain reaction and sequencing for typing rhinovirus RNA
  publication-title: J Med Virol
  doi: 10.1002/jmv.1890440403
– volume: 75
  start-page: 101
  year: 2005
  ident: 10.1016/j.vaccine.2011.11.063_bib0130
  article-title: Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses
  publication-title: J Med Virol
  doi: 10.1002/jmv.20243
– volume: 194
  start-page: 1283
  year: 2006
  ident: 10.1016/j.vaccine.2011.11.063_bib0115
  article-title: Epidemiological profile and clinical associations of human bocavirus and other human parvovirus
  publication-title: J Infect Dis
  doi: 10.1086/508219
– volume: 38
  start-page: 1170
  year: 2000
  ident: 10.1016/j.vaccine.2011.11.063_bib0065
  article-title: Comparison of classic and molecular approaches for the identification of untypeable enteroviruses
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.38.3.1170-1174.2000
– year: 2011
  ident: 10.1016/j.vaccine.2011.11.063_bib0135
  article-title: Comparison of the novel ResPlex III assay and existing techniques for the detection and subtyping of influenza virus during the influenza season 2006–2007
  publication-title: Eur J Microbiol Infect Dis
– volume: 98
  start-page: 123
  year: 2009
  ident: 10.1016/j.vaccine.2011.11.063_bib0120
  article-title: Multiple viral respiratory pathogens in children with bronchiolitis
  publication-title: Acta Paediatr
  doi: 10.1111/j.1651-2227.2008.01023.x
– volume: 3
  start-page: 97
  year: 1993
  ident: 10.1016/j.vaccine.2011.11.063_bib0010
  article-title: Clinical influenza virus and the embryonated hen's egg
  publication-title: Med Virol
  doi: 10.1002/rmv.1980030206
– volume: 160
  start-page: 191
  year: 1989
  ident: 10.1016/j.vaccine.2011.11.063_bib0020
  article-title: Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs
  publication-title: J Infect Dis
  doi: 10.1093/infdis/160.2.191
– volume: 41
  start-page: 149
  year: 2003
  ident: 10.1016/j.vaccine.2011.11.063_bib0055
  article-title: Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.41.1.149-154.2003
– volume: 29
  start-page: 179
  year: 2004
  ident: 10.1016/j.vaccine.2011.11.063_bib0050
  article-title: Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement
  publication-title: J Clin Virol
  doi: 10.1016/S1386-6532(03)00122-7
– volume: 68
  start-page: 452
  year: 2002
  ident: 10.1016/j.vaccine.2011.11.063_bib0060
  article-title: Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: comparison of viruses and genotypes responsible for different disease manifestations
  publication-title: J Med Virol
  doi: 10.1002/jmv.10225
– volume: 196
  start-page: 1321
  issue: November (9)
  year: 2007
  ident: 10.1016/j.vaccine.2011.11.063_bib0080
  article-title: Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays
  publication-title: J Infect Dis
  doi: 10.1086/521308
– volume: 45
  start-page: 2116
  issue: July (7)
  year: 2007
  ident: 10.1016/j.vaccine.2011.11.063_bib0085
  article-title: Real-time PCR for diagnosis of human bocavirus infections and phylogenetic analysis
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.00027-07
– volume: 10
  start-page: 32
  year: 1979
  ident: 10.1016/j.vaccine.2011.11.063_bib0140
  article-title: Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.10.1.32-36.1979
– volume: 50
  start-page: 560
  year: 2010
  ident: 10.1016/j.vaccine.2011.11.063_bib0110
  article-title: Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production
  publication-title: Clin Infect Dis
  doi: 10.1086/650171
– volume: 26
  start-page: 3332
  year: 2008
  ident: 10.1016/j.vaccine.2011.11.063_bib0045
  article-title: A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.03.075
SSID ssj0005319
Score 2.1152802
Snippet ► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI,...
Highlights► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno,...
This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after...
Highlights * Multiplex PCR screening of clinical specimens from acute respiratory tract infections. * Viruses found were influenza, entero/rhino, corona,...
SourceID pubmedcentral
proquest
pubmed
crossref
fao
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 517
SubjectTerms Adenovirus
Adenoviruses
Adventitious viruses
Allergy and Immunology
Animals
Binding sites
Blood
Bocaparvovirus
Bocavirus
Cell culture
Cell Line
Coinfection - virology
Coronavirinae
Coronavirus
Dogs
Eggs
Enterovirus
Germany
Humans
Influenza
Influenza vaccine
Influenza virus
inoculum
MDCK cells
Multiplex Polymerase Chain Reaction
Mutation
Orthocoronavirinae
Orthomyxoviridae
Parainfluenza virus
polymerase chain reaction
Respiratory syncytial virus
Respiratory tract
Respiratory Tract Infections - diagnosis
Respiratory Tract Infections - virology
Rhinovirus
screening
Vaccines
Virology - methods
Virus Cultivation - methods
Virus Diseases - diagnosis
Virus Diseases - virology
Virus isolation
Viruses
Viruses - genetics
Viruses - growth & development
Viruses - isolation & purification
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYEIgXBAW2wEBGQntatiRObOcJoUE1QEWVtqK-WbbjjE4oGU07afz13OWToX3w2vjy0Tuff-c7_46Qd3EuuRHc-FkuMM3IAl-aPPG1dcaEsQ4Th4Hi5Bs_msVf5sm83XCr2rLKzifWjjorLe6RHwCSF7CWcxa8P__lY9cozK62LTQ2yH2kLsOSLjEXQ4kHqxt7QJgRw2sE8-EEz8HZ_oW2mLpuWDyRyJOzm9amjVyX1yHQfwsp_1qZxk_I4xZS0g-NDTwl91wxIg-aJpOXI_Jw0qbPR2R32hBVX-7Rk-HcVbVHd-l0oLAGmdF3rJKpj-rSTvwZOf0MhlprkpY5XTTtTX5rerFYritXwS908vHwK2Uwnfl0TDEpUFFdZNRicwq0LxTE6niNFThYcU2XQ66_u9FzMht_Ojk88ttGDb6FcGPlO55KIVzqhNbM2MjFApEcICOnozi3MnGJyR23LDKRtHGWM2MYDJOZTrPEsRdksygLt01omOnM6UC6NGGxTCMdBwZApsk4QCXujEfiTkXKtizm2Ezjp-rK1c5Uq1mFmoUIR4FmPbLfi503NB53CfBO_6o7owpeVcFCc5eguE7QVa1vqFSoqkgF6jiosWgwD5E0DeI6j8hesoU_Daz5n4dug4kqfQoLg5odR7iNBbEvPCDyyE5nt2p4hX4yeeRtfxkcCxqGLly5hjEAYxIAK3gLesOYFHScCin5bUMkUgax0CNbzWTpFRAhu2Aawf3FlWnUD0Dq86tXisWPmgJdgFORIXt5-8e9Io_gr8DSIz8Md8jmarl2rwFDrsyb2lH8AZ2DcCY
  priority: 102
  providerName: ProQuest
Title Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X11018597
https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X11018597
https://dx.doi.org/10.1016/j.vaccine.2011.11.063
https://www.ncbi.nlm.nih.gov/pubmed/22119922
https://www.proquest.com/docview/1497392630
https://www.proquest.com/docview/1678529942
https://www.proquest.com/docview/912797886
https://www.proquest.com/docview/918053731
https://pubmed.ncbi.nlm.nih.gov/PMC7130813
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGEIgXBAW2wEBGQnta2iRObOdxlFUdU6uKrahvlp04oxNKp6adNB7427nLR7vCxhAvaZvcOVHufPdzfR-EfAgzyY3gxk0zgduMzHOlySJXJ9YYP9R-ZHGhOBjy_jj8PIkmW6Tb5MJgWGVt-yubXlrr-kynfpudy-m0c-qVvtyb-Fh0CnAxZrCHArW8_fNGmAcrm3sgsYvU6yyezkX7Sie4fV1V8sRinpzd5Z8eZHp2Gwr9PZjyhnfqPSNPa1hJD6snf062bN4ij6pGk9ct8nhQb6G3yP6oKlZ9fUDP1rlXxQHdp6N1GWvgaX3FSJkyXZc27C_I-TEoaylNOsvotGpx8kPTq-l8WdgCztDBp-4JZTCl-ahHcWOgoDpPaYINKlDHkBEj5DVG4WDUNZ2v9_ubgV6Sce_orNt362YNbgJLjoVreSyFsLEVWjOTBDYUiOYAHVkdhFkiIxuZzPKEBSaQSZhmzBgGZDLVcRpZ9ops57Pc7hLqpzq12pM2jlgo40CHngGgaVIOcIlb45CwEZFK6krm2FDju2pC1i5ULVmFkoVVjgLJOqS9YrusSnncx8Ab-asmTxUsqwJncx-juI3RFrV9KJSvikB56g8ddohccW5Mg3-56S6oqNLn4BzU-DTAv7Jg_Qs3CByy1-itWj9CGAsAx5x5Dnm_ugzGBRVD53a2BBqAMhEAFhyC3kETg4xjISX_G4nEskHMd8hONVlWAgiwwmAcwPhiYxqtCLD8-eaVfPqtLIMuwLBIn73-_1f2hjyBXxia5Pr-HtlezJf2LWDMhXlXGhE4iomAo-zC94eHxyf9IXx-PBqOvvwCVLN_JA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF61qXhcEIRHDQUWCXqqW9trr-0DQtA2SkgTRbSpclt27XVJhZISJ0XhR_EbmfGToj649BrvrGPP7Mw33tlvCHnrJgFXPldmnPi4zcgsM1CJZ8pIK2W70vY0Joq9Pm8P3c8jb7RCfpdnYbCssvSJmaOOpxF-I98BJO9DLOfM-nD2w8SuUbi7WrbQyM2iq5c_IWVL33f2QL_vHKe1f7TbNouuAmYE2Hhuag5ptq9D7UvJVORo10fYAWFcS8dNosDTnko0j5ijnCBy44QpxWBYEMsw9jSDeVfJmssglWmQtU_7_cGXuqiEZa1EILFx4cGtUX1maOd0-1xGuFme84YidShnV0XD1UROL8O8_5Zu_hULWw_JgwLE0o-51T0iK3rSJHfytpbLJrnbKzbsm2RzkFNjL7foUX3SK92im3RQk2aDTPMY63Kyw8G0FH9MTjqwNDLbodOEjvOGKr8kPR_PFqlO4Rfa29vtUgYOhA9aFLchUionMY2wHQZaNApiPb7Emh-s8aazurqgnOgJGd6KEp-SxmQ60euE2rGMtbQCHXrMDUJHupYCWKtiDuCMa2UQt1SRiAredGzf8V2UBXKnotCsQM1CTiVAswbZrsTOcuKQmwR4qX9RnooFPy4gtN0k6F8mqNPCG6XCFqkjLHFoZejXGtlI0waZpEGCSrIAXDmQ-p-broOJCnkCoUgMDx38cAbZNtzAMchGabei_gvV8jXIm-oyuDI0DDnR0wWMAeDkATzCKegVY0LQcegHAb9uSIAkRcw2yLN8sVQKcJDPMHRgfv_CMqoGINn6xSuT8beMdN0HNxbY7Pn1D_ea3Gsf9Q7EQafffUHuw2vBwifTtjdIYz5b6JeAYOfqVeE2KPl6257qDx-0r98
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe2ISZeEJSPBQYYCfa0rImdxMkDQmilWimdKm1FfTN24oxOqB1NO1T-NP467vLJ0D542Wvjc5rc-e538fl3hLzx0jDQItB2kgrcZuSOHerUt1VstHY95foGE8XBYXAw8j6N_fEa-V2dhcGyyson5o46mcX4jbwNSF5ALA-4007Lsohhp_v-7IeNHaRwp7Vqp1GYSN-sfkL6lr3rdUDXbxnrfjzeP7DLDgN2DDh5YZsAUm5hIiOU4jpmxhMIQSCkG8W8NA594-vUBDFnmoWxl6Rcaw7DwkRFiW84zLtO7gjuu7jGxFg05SU8byoCKY4Hr8AZN6eH2qd75yrGbfOCQRRJRAN-VVxcT9XsMvT7bxHnX1Gx-4DcL-Es_VDY30OyZqYtcrdocLlqkc1BuXXfIjvDgiR7tUuPmzNf2S7docOGPhtkWl-wQic_Jkwr8UfkpAeLJLciOkvppGit8kvR88l8mZkMfqGDzn6fcnAlwbBLcUMio2qa0BgbY6BtoyBW5ius_sFqbzpv6gyqiR6T0a2o8AnZmM6mZotQN1GJUU5oIp97YcSU52gAuDoJAKYFRlvEq1Qk45JBHRt5fJdVqdypLDUrUbOQXUnQrEX2arGzgkLkJoGg0r-szseCR5cQ5G4SFJcJmqz0S5l0ZcakI4-cHAc7YxcJ2yCntEhYS5bQq4BU_3PTLTBRqU4gKMnREcNPaJB3ww2YRbYru5XNX6gXskVe15fBqaFhqKmZLWEMQCgfgBJOQa8YE4GOIxGGwXVDQqQr4q5FnhaLpVYAQ2bDiMH84sIyqgcg7frFK9PJt5x-XYBDC13-7PqHe0U2wT_Jz73D_nNyD94KKz7cbZONxXxpXgCUXeiXuc-g5OttO6k_MVCyrg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Isolation+of+influenza+viruses+in+MDCK+33016PF+cells+and+clearance+of+contaminating+respiratory+viruses&rft.jtitle=Vaccine&rft.au=Roth%2C+Bernhard&rft.au=Mohr%2C+Hannah&rft.au=Enders%2C+Martin&rft.au=Garten%2C+Wolfgang&rft.date=2012-01-11&rft.pub=Elsevier+Ltd&rft.issn=0264-410X&rft.eissn=1873-2518&rft.volume=30&rft.issue=3&rft.spage=517&rft.epage=522&rft_id=info:doi/10.1016%2Fj.vaccine.2011.11.063&rft_id=info%3Apmid%2F22119922&rft.externalDocID=PMC7130813
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X11X00531%2Fcov150h.gif